Novogene Europe Experts Discuss Metabolite Identification Challenges in Technology Networks
Untargeted metabolomics can reveal thousands of molecular features, but detecting a signal does not necessarily mean that the underlying metabolite has been confidently identified. Understanding this distinction is essential for reliable data interpretation and meaningful biological insights.
In a new expert perspective published by Technology Networks, Carolina Jiang Zheng, Senior Product Manager, and Dr Wenjie Bi, Bioinformatics Consultant at Novogene Europe, explore the challenges of metabolite identification and the importance of confidence-aware annotation in untargeted metabolomics research.
Titled Detection Isn’t Identification: Building Confidence in Untargeted Metabolomics, the article examines how multiple layers of analytical evidence, including accurate mass, MS/MS fragmentation, spectral databases and authentic reference standards, contribute to metabolite annotation. It also discusses the importance of quality control, transparent confidence reporting and careful interpretation of molecular findings.
The authors further consider how metabolomics can complement other omics approaches to provide broader biological context, while emphasising that integrated data cannot replace the chemical evidence needed to establish metabolite identity.
The article offers practical perspectives for researchers seeking to move from molecular feature detection towards more confident annotation and biologically meaningful interpretation.
Read the full article on Technology Networks:
Detection Isn’t Identification: Building Confidence in Untargeted Metabolomics